Scientists tap into lymph fluid to unlock MS mysteries
NCT ID NCT05162638
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects lymph fluid from the chest of 24 people (some with MS, some healthy) to compare immune cells in the lymph system versus blood. In MS participants, fluid is also collected before and after treatment with the drug ofatumumab. The goal is to understand how the immune system changes with MS and treatment, not to test a new therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ofatumumab
- What this could lead to
- If successful, this could reveal how immune cells travel in the body and how MS drugs affect them, pointing toward better treatments.
- What could go wrong
- This is a very small, early-stage study (24 people) focused on observation, not treatment. The procedure carries risks like infection or bleeding, and findings may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Can a blood pressure pill slow MS disability?
- Water workouts could be the key to back pain relief